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Background: Artemin, a member of the glial cell line-derived neurotrophic factor family, is known to have a
variety of neuronal functions, and has been the subject of attention because it has interesting effects, including
bi-directional results in modulation in neuropathic and inflammatory pain. It has been shown that the overexpression
of artemin is associated with an increase in the expression of TRP family channels in primary afferents and subsequent
hyperalgesia, and an increase in neuronal activity. The purpose of this study was to examine the peripheral synthesis
of artemin in inflammatory and neuropathic pain models, and to demonstrate the effects of long-term or repeated
application of artemin in vivo on pain behaviors and on the expression of TRP family channels. Further, the regulatory
mechanisms of artemin on TRPV1/A1 were examined using cultured DRG neurons.
Results: We have demonstrated that artemin is locally elevated in skin over long periods of time, that artemin signals
significantly increase in deep layers of the epidermis, and also that it is distributed over a broad area of the dermis. In
contrast, NGF showed transient increases after peripheral inflammation. It was confirmed that the co-localization of
TRPV1/A1 and GFRα3 was higher than that between TRPV1/A1 and TrkA. In the peripheral sciatic nerve trunk, the
synthesis of artemin was found by RT-PCR and in situ hybridization to increase at a site distal to a nerve injury. We
demonstrated that in vivo repeated artemin injections into the periphery changed the gene expression of TRPV1/A1 in
DRG neurons without affecting GFRα3 expression. Repeated artemin injections also induced mechanical and heat
hyperalgesia. Using primary cultured DRG neurons, we found that artemin application significantly increased TRPV1/A1
expression and Ca2+ influx. Artemin-induced p38 MAPK pathway regulated the TRPV1 channel expression, however
TRPA1 upregulation by artemin is not mediated through p38 MAPK.
Conclusions: These data indicate the important roles of peripherally-derived artemin on the regulation of TRPV1/A1 in
DRG neurons in pathological conditions such as inflammatory and neuropathic pain.Background
Artemin, a member of the glial cell line-derived neuro-
trophic factor family, is involved in a variety of neuronal
functions such as development, regeneration and regula-
tion of gene expression and neural activity. Artemin
binds to the GFRα3/RET receptor complex and then
activates several intracellular signaling pathways [1].
Among several neurotrophic factors working in nocicep-
tive pathways, artemin has been the subject of attention* Correspondence: noguchi@hyo-med.ac.jp
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article, unless otherwise stated.due to its unique characteristics that were recently re-
ported. One important characteristic is that the receptor
of artemin, GFRα3, is selectively expressed in adults to a
subpopulation of nociceptive sensory and sympathetic
neurons. This is also colocalized with the transient re-
ceptor potential (TRP) ion channel family proteins [2,3].
TRPV1/TRPA1 is a member of TRP family of cation
channels [4] and is expressed by a subset of small-sized
DRG or trigeminal ganglia neurons [5-7]. In addition to
the established effect of TRPV1 on noxious heat transduc-
tion, there have been many reports on the role of TRPA1;
various kinds of noxious compounds activate TRPA1
through covalent modification of cysteines [5,8-13], andCentral. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/4.0), which permits unrestricted use,
, provided the original work is properly credited. The Creative Commons Public
mons.org/publicdomain/zero/1.0/) applies to the data made available in this
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4-hydroxynonenal, bradykinin, intracellular pH and CO2
[8,14-16]. Several papers have indicated that TRPA1 is an
important component of the transduction machinery
through which noxious irritants and endogenous proalge-
sic molecules depolarize nociceptors to elicit inflammatory
pain [17,18]. Therefore, there has been interest in the
study of TRPA1 as it is crucial in pathological pain trans-
duction, and the regulatory mechanisms of TRPA1 in per-
sistent pain condition require further studies.
It has been reported that artemin has bi-directional re-
sults in the modulation in neuropathic and inflammatory
pain. For example, administration of artemin prevented
changes in the nociceptive pathway after peripheral
nerve injury [19-22], and reversed nerve injury-induced
pain behaviors [20]. Conversely, artemin is reported to
have a pronociceptive role in peripheral inflammation or
nerve injury. The overexpression of artemin increased
the expression of TRP channels in primary afferents and
subsequent hyperalgesia [23], and artemin administra-
tion induced a significant potentiation of TRPV1 func-
tion in vitro and thermal hyperalgesia in vivo [24].
Further, artemin may have different effects on TRPV1
and TRPA1, namely an inhibitory effect on TRPA1 activ-
ity [25], and a pronociceptive role on TRPV1 function
[24]. Therefore, we intended to examine in detail the
long-term effects of artemin on pain behaviors and on
the expression of TRP family channels using in vivo and
cultured DRG neurons. We observed an increase in arte-
min expression in the epidermis of inflamed skin and also
peripheral nerves distal to a nerve injury. Increased arte-
min at peripheral sites was shown to affect the gene ex-
pression of TRPA1/V1 in primary afferents both in vivo
and in vitro. All findings in the present study suggest the
pivotal role of peripheral tissue-derived artemin in the
regulation of TRPA1/V1 expression in primary afferents.
Results
Artemin increased locally in skin over long periods of
time, whereas NGF showed only transient increases after
peripheral inflammation
In order to examine the local synthesis of growth factors
after tissue inflammation, we injected complete Freund’s
adjuvant (CFA) into rats’ plantar surfaces and measured
the changes in the mRNA of nerve growth factor (NGF)
and artemin in the skin using RT-PCR (Figure 1A). The
NGF mRNA level almost doubled compared to the naive
level after 3 hours, and sustained the same level until
12 hours, but returned to normal by 24 hours post-
injection (Figure 1B). In contrast, artemin mRNA levels
showed dramatic increases, more than doubling 3 hours
after injection, and remaining elevated until 7 days after
injection, where the peak was at 1 day with a six-fold in-
crease (p < 0.05 versus naive, Figure 1C).To identify the source of NGF and artemin synthesis
in inflamed tissue, we used in situ hybridization histo-
chemistry (ISHH) for the plantar skin (Figure 1D-S).
Consistent with the RT-PCR data, an increase in NGF
mRNA was detected 3 hours after CFA injection
(Figure 1E, I). Dark-field photomicrographs for NGF
showed that clusters of silver grains increased mainly
in the dermis and hypodermis (Figure 1H-I), and it
was presumed that the NGF was expressed mainly in
keratinocytes in the epidermis (Figure 1G) and vascu-
lar smooth muscle (Figure 1K). NGF mRNA was faintly
expressed one day after CFA injection (Figure 1F, J). By
contrast, the increase in artemin mRNA was mild com-
pared to that of NGF. As seen in the dark-field photo-
micrograph one day after CFA injection, a high intensity
of silver grains was observed over a broad area of the epi-
dermis and dermis (Figure 1P-R). The silver grains in the
epidermis were increased in density and scattered through
deep layers of the epidermis. Signals were also detected in
cells located in the dermis and hypodermis. The
artemin-generating cells include keratinocytes in the
epidermis (Figure 1O), and eosin-labeled immune cells
in the dermis (Figure 1S) according to the magnified
bright-field microphotographs.
Artemin increases in the peripheral sciatic nerve
following Wallerian degeneration after nerve injury
We examined the expression of NGF and artemin in
peripheral nerves after nerve injury. After the spinal
nerve ligation (SNL), NGF and artemin mRNA showed
different patterns of increase at a point distal to the
nerve injury. NGF showed a small increase that signifi-
cantly increased at 14 and 21d after nerve injury. In con-
trast, artemin mRNA showed a gradual and large
increase, which significantly increased from 1–3 weeks
after nerve injury (Figure 2A-C). To determine the area
expressing increased artemin mRNA, we performed
ISHH on the sciatic nerve after SNL. We found that large
portion of the sciatic nerve had Wallerian degeneration,
and these degenerated areas coincided with areas express-
ing increased artemin mRNA at 14d after nerve injury
(Figure 2D-G). Collectively, artemin showed a longer in-
crease in synthesis at peripheral sites in both inflammation
and nerve injury models compared to NGF.
Repeated artemin injections changed the gene expression
of TRPV1 and TRPA1 in DRG neurons
NGF is believed to be an important modulator of gene
expression in primary afferents. The results presented in
Figures 1 and 2 suggested that the increase in artemin
has a longer time course after peripheral inflammation
and nerve injury compared to NGF. A previous study in-
dicated that overexpression of artemin caused increased
TRPV1 in the DRG in vivo [2]. Therefore, we examined
Figure 1 (See legend on next page.)
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Figure 2 Artemin increases in peripheral sciatic nerve following
Wallerian degeneration after spinal nerve ligation. A-C: NGF and
artemin mRNA levels in the ipsilateral sciatic nerve were measured
by PT-PCR. The NGF mRNA level increased at 14 and 21 days after
SNL (B, n = 4, mean ± SEM, **p < 0.01, *p < 0.05 compared with
naïve). Artemin mRNA levels gradually increased and continued until
21 days after SNL (C, n = 4, mean ± SEM, **p < 0.001, ***p < 0.0001,
compared with naïve). D-G: The area of the L5 spinal nerve in the
ipsilateral sciatic nerve showed Wallerian degeneration in the bright-field
microphotographs 14 days after ligation and ISHH revealed that artemin
mRNA was in the same area as the Wallerian degeneration. Bars: 50 μm
(D-G) POD; post operative day.
(See figure on previous page.)
Figure 1 Artemin increases locally in skin over long periods of time, whereas NGF shows a transient increase after peripheral
inflammation. A-C: The NGF mRNA level almost doubled compared to the naïve level after 3 hours and sustained the same level until 12 hours,
but returned to the normal level by 24 hours post CFA injection. In contrast, the artemin (ARTN) mRNA level showed a dramatic increase, more
than doubling in 3 hours, and remained elevated until 7 days after injection (n = 4, mean ± SEM, ***p < 0.001, **p < 0.01, *p < 0.05, compared with
naïve). D-S: ISHH for plantar skin revealed the source of NGF and artemin. NGF mRNA was expressed 3 hours after CFA injection (E, I) and it was
expressed from the keratinocytes in the epidermis (G, arrows) and vascular smooth muscles in the dermis (K, arrows). Artemin mRNA was observed
over a broad area of the epidermis 24 hours after CFA injection as seen in the dark-field photomicrograph (N and R). The artemin-generating cells
were presumably keratinocytes in the epidermis (O, arrows) and eosin-labeled immune cells in the dermis according to the magnified bright-field
microphotographs (S, arrows). Epi: epidermis, DM: dermis. Bars: 100 μm (D-F, H-J, L-N, P-R), 50 μm (G, K, O), 10 μm (S).
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DRG neurons after repeated artemin injections, using
RT-PCR and ISHH of DRG neurons. Five days of injec-
tions of artemin (20 μg/ml, 100 μl/injection) into the
planter surface significantly induced TRPV1 and TRPA1
mRNA in the DRG measured by RT-PCR (Figure 3A-C).
Next, we examined the mRNA changes in the DRG neu-
rons using ISHH and measured the signal-to-noise (S/N)
ratio in each DRG neuron plotted on scatterplot dia-
grams (Figure 3D-O). The number of TRPV1 mRNA-
expressing neurons was not significantly increased after
repeated artemin injections (Figure 3D-G, P); however,
the signal intensity was increased in small and medium-
sized DRG neurons (Figure 3Q), and these increases
were statistically significant. Next, the TRPA1 mRNA
was examined in DRG neurons after repeated artemin
injection. The signal intensity of TRPA1 mRNA in-
creased in small and medium-sized DRG neurons after
artemin injection compared to controls (Figure 3H-K, R),
but the total number of TRPA1-expressing neurons did
not increase compared to the PBS control (Figure 3P).
This pattern of increase of TRPA1 mRNA was similar to
that in TRPV1. We also investigated GFRα3 mRNA and
found that repeated artemin injection did not change the
expression of GFRα3 (Figure 3L-P). These results con-
firmed that persistent artemin administration in the per-
ipheral tissue significantly increased the gene expression
of TRPA1 and TRPV1 in small to medium-sized DRG
neurons without changing their receptor profiles.The co-localization of TRPV1/A1 and GFRα3 was higher
than that of TRPV1/A1 and TrkA
Next, we compared the receptor of artemin in primary af-
ferents with that of NGF. We studied the co-localization
of TRPA1 or TRPV1 with Trk A or GFRα3 in DRG neu-
rons (Figure 4). We found that 43.2 ± 3.9% of the TRPA1
positive neurons and 47.5 ± 6.2% of the TRPV1 positive
neurons expressed TrkA. In the case of the artemin recep-
tor, 68.5 ± 5.4% of TRPV1 positive neurons overlapped
with GFRα3 mRNA, and 84.1 ± 2.6% of TRPA1 expressing
neurons were also labeled with GFRα3 mRNA. These re-
sults indicated that TRPA1/V1-expressing primary affer-
ent neurons contained the artemin receptors at a higher
Figure 3 (See legend on next page.)
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Figure 3 Repeated artemin plantar injections changed the gene expressions of TRPV1 and TRPA1 in DRG neurons. A-C: Artemin was
injected into the planter surface once a day for 5 days (20 μg/ml, 100 μl/injection, PBS control, n = 8 each groups) and TRPV1 and TRPA1 mRNA
levels in DRG were both increased significantly compared with control (mean ± SEM, *p < 0.05). D-O, ISHH and the scatterplots of TRPV1, TRPA1
and GFRα3 mRNAs in DRG neurons after PBS (D, F, H, J, L, N) or artemin injection (E, G, I, K, M, O). Each DRG neuron was plotted with the
signal-to-noise (S/N) ratio and its cross-sectional area. The number of TRPV1/TRPA1 mRNA expressing neurons is quantified (P) and the mean
S/N ratio in positive neurons was shown in Q and R. The total number of TRPV1 or TRPA1 mRNA-labeled neurons was not significantly
increased (P), while the signal intensity of both mRNAs after artemin injection were clearly increased after repeated artemin injection in
small and medium-sized DRG neurons compared to PBS control (Q, R) (mean ± SEM, *p < 0.05). Repeated artemin injection did not change
the profiles of GFRα3, which is a receptor of artemin. Bars: 100 μm (D, E, H, I, L, M).
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important role on the regulation of TRP channels in pri-
mary afferents, as does NGF.
Continuous artemin injection into the plantar surface
caused mechanical and heat hyperalgesia
An analysis of expression of the ligands and receptors of
artemin/NGF in primary afferent neurons indicated a
physiological role in pain modulation. Although NGF
has been believed to be one of the major contributing
factors in inflammatory pain, the results of some previ-
ous studies suggested that artemin might cause hyper-
algesia after peripheral inflammation. Therefore, in order
to examine the role of artemin on pain behaviors, we
injected recombinant mouse artemin (100 μg/ml, 100 μl)
into the plantar surface once and measured mechanical
and heat thresholds for 5 days. A single injection of arte-
min, however, did not induce hyperalgesia either in
mechanical or in thermal testing (Figure 5A, B). Next, we
examined the effects of repeated artemin administrationFigure 4 The co-localization of TRPV1/A1 and GFRα3 was
higher than that of TRPV1/A1 and TrkA. A-D: Colocalization of
TRPV1 or TRPA1 mRNA (clusters of solver grains; triangle heads)
and TrkA (A and B) or GFRα3 (C and D) mRNA (brown cells) using
double ISHH with 35S-labeled antisense TRPV1 or TRPA1 probes
combined with DIG-labeled TrkA or GFRα3 probe. The brightfield
and darkfield photographs are merged. Arrows indicate examples of
double-labeled neurons. Bars: 50 μm (A-D).into the plantar surface. We injected artemin (20 μg/ml,
100 μl/injection, PBS control, n = 8 for each group) once a
day for 5 days and tested heat and mechanical thresholds
(Figure 5C, D). Significant differences were found from
the second day in both types of testing and they continued
until the day following the final injection. These results
suggested that the continuous generation of artemin
might change gene expression in DRG neurons involved
in hyperalgesia.
Artemin increases TRPV1/A1 expression and Ca2+ activity
in primary cultured DRG neurons
Using DRG primary culture neurons, we used RT-PCR
to determine whether artemin obtained either from in-
flamed peripheral tissue or damaged nerves can directly
change the gene expression of TRPV1 and TRPA1 in
primary afferents (Figure 6A-D). Application of artemin
into culture medium induced TRPA1 as well as TRPV1
(Figure 6A). There was a significant increase in mRNA
levels of TRPV1 and TRPA1 after 18 hours of incubation
with artemin (100 ng/ml), but not in those of GFRα3
(Figure 6B-D). These results confirmed that artemin dir-
ectly regulates the gene expression of TRPV1 and
TRPA1 in DRG neurons.
Next, to test whether the increase in TRPV1/A1
mRNA produced by artemin is physiologically relevant,
we used a Fura-2-based Ca2+ imaging method with
DRG primary cultured neurons, incubated in the same
medium as in the previous study (Figure 7A-F, I-N).
Firstly, cell viability was checked with a high-
concentration solution of KCl. Cells activated by KCl
were considered to be neurons. TRPV1-expressing
neurons were confirmed by the application of capsa-
icin (200 nM). The number of capsaicin responsive
neurons was significantly larger in artemin-treated
neurons than amongst vehicle-treated neurons (Figure 7G).
We also compared the increase in the Fura ratio (the ratio
of 340/380 nm values) between the two treatment groups
(Figure 7H), and found that the artemin-treated DRG neu-
rons showed a higher Fura ratio than the vehicle-treated
neurons. Next, we examined TRPA1-expressing neurons
in the same DRG cultured neurons. TRPA1 positive neu-
rons were confirmed by the application of AITC (100 μM)
and capsaicin (1 μM). The number of AITC/capsaicin
Figure 5 Continuous artemin injection into the plantar surface caused mechanical and heat hyperalgesia. A-B: Artemin (100 μg/ml,
100 μl/injection, PBS control n = 8) was injected into the planter surface only once and mechanical (A) and thermal (B) thresholds were tested
after 5 days. A single dose of artemin, however, did not induce either mechanical or thermal hyperalgesia. C-D: Artemin (20 μg/ml, 100 μl/injection,
PBS control, n = 8 each groups) was injected once a day for 5 consecutive days, resulting in significant changes in mechanical (C) and heat (D)
thresholds, *p < 0.05; **p < 0.01; ***p < 0.001versus PBS group (two-way repeated ANOVA followed by Bonferroni post-test).
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cultured neurons than vehicle-treated neurons (Figure 7O).
However, the Fura ratio in responsive neurons did not
show any difference between the two groups (Figure 7P).
Differential regulation of TRPV1/A1 expression by artemin
in primary afferents
Previous studies have reported that phosphorylation of
p38 MAPK is involved in the regulation of TRPV1
mRNA expression in DRG neurons [26,27]. To test if
the increase of TRPV1 and TRPA1 expressions in DRG
neurons by artemin is mediated by the p38 MAPK
pathway, we performed immunohistochemistry using
a phospho-p38 antibody (activated p-38 antibody)
(Figure 8A-C). Previous studies reported that p-p38 is
present only in 15% of DRG neurons in naive rats [26].
Although repeated PBS plantar injection increased the
number of p-p38-positive neurons compared to naive neu-
rons, repeated artemin plantar injection (2 μg) increased
them to a greater degree than PBS control neurons
(Figure 8D). The difference between the PBS injected
group and artemin injected group was statistically signifi-
cant. Furthermore, we performed double-labeling experi-
ments for TRPV1 or TRPA1 mRNA and p-p38 by a
method combining ISHH and immunohistochemistry
(Figure 8E, F). A number of TRPV1 or TRPA1 mRNA
expressing neurons in the artemin injection groupwere also labeled with p-p38 MAPK. The percentages
of colocalization of TRPV1 or TRPA1 in p-p38-labeled
neurons were significantly increased after artemin in-
jection (Figure 8G, H). Therefore, these results led us
to examine a possible relationship between the in-
creases in TRPV1 and TRPA1 mRNA in DRG neurons
and the p-38 MAPK pathway.
Based on our previous results, we hypothesized that
increases in TRPV1 and TRPA1 produced by artemin
are mediated through the p38 MAPK pathway. To test
this, we examined the effect of SB203580 on the ex-
pression of TRPV1/A1 using RT-PCR of primary cul-
tured DRG neurons (Figure 8I-K). We co-administrated
SB203580, 2 μM or 20 μM and artemin simultaneously and
incubated the cells for 18 hours. Twenty μM of SB203580
significantly reversed the increase of TRPV1 mRNA
(Figure 8I, J), however SB203580 had no effect on the
artemin-induced TRPA1 upregulation (Figure 8I, K). It
suggested that p38 MAPK is involved in the regulation
of TRPV1 upregulation by artemin, but not of TRPA1.
Discussion
In recent years, there has been interest in the study of
artemin, a GDNF family member, because it has shown
a very wide variety of effects, including bi-directional
results in the modulation in neuropathic and inflamma-
tory pain. Previous studies suggested a possible role of
Figure 6 Artemin increased the mRNA of TRPA1 and TRPV1 in
primary cultured DRG neurons. A: Artemin directly changed the
gene expression of TRPV1 and TRPA1 in cultured DRG neurons using
RT-PCR. B-D: Quantitative analysis showed a significant increase in
mRNA levels of TRPV1 and TRPA1 after 18 hours of incubation
with artemin (100 ng/ml), but not with GFRα3. (mean ± SEM,
*p < 0.05, ***p < 0.001, compared with the vehicle group).
Ikeda-Miyagawa et al. Molecular Pain  (2015) 11:8 Page 8 of 15artemin as a survival factor of sensory and sympathetic
neurons in vitro and in vivo. Systemic or intrathecal ad-
ministration of artemin was shown to prevent the alter-
ation of the nervous system that occurs after peripheral
nerve injury [19-22]. Nerve injury-induced pain behav-
iors were also dose-dependently reversed by these treat-
ments [20]. In contrast, artemin is known to have a
pivotal role in pain hypersensitivity after peripheral in-
flammation or nerve injury. For example, the important
paper by Elitt et al. [2] reported that the overexpression
of artemin increased the expression of TRPV1 and TRPA1
in primary afferents and subsequent hyperalgesia, and
increased neuronal activity. The application of artemin
induced a significant potentiation of TRPV1 function
in vitro and thermal hyperalgesia [24]. These bi-directional
effects have been reported with another well-known neuro-
trophic factor, nerve growth factor (NGF). NGF is known
to have an important role in the positive regulation of many
pronociceptive molecules in primary afferents and also to
increase pain behaviors. However, NGF has been found to
reverse hyperalgesia in a neuropathic pain model when it
was applied to a nerve injury site [28,29]. Bi-directionaleffects of artemin in persistent pain models clearly require
further study.
Another interesting point is that artemin may have dif-
ferent effects on TRPV1 and TRPA1. We reported that
short-term application of artemin inhibits TRPA1 chan-
nel activity and subsequent pain behaviors [25]. How-
ever, acute application of artemin was reported to
induce potentiation of TRPV1 and produce acute ther-
mal hyperalgesia [24]. Overall, these findings suggest
that acute administration changes the expression of
TRPA1 and TRPV1 differentially, and also that acute
and long-term exposure to artemin has different effects
on the activity of TRP channels. Therefore, the purpose
of this study was to examine the effects of long-term or
repeated application of artemin on pain behaviors and
on the expression of TRP family channels using in vivo
and cultured DRG neurons. In the behavioral analysis in
the present study, we confirmed that the repeated or
continuous injection of artemin into the rat plantar sur-
face induced mechanical and heat hyperalgesia. This is
consistent with previous papers, in which artemin was
injected peripherally into the mouse hindpaw [24,30],
and anti-artemin partially reversed CFA-induced mech-
anical hyperalgesia [31].
In the present study, we found that artemin mRNA
was increased in the epidermis after CFA injection. Pre-
vious papers showed an artemin increase in the skin
after CFA-induced peripheral inflammation [24,30] but
lacked a morphological analysis of the skin. The cells
expressing increased artemin mRNA have not been
precisely identified but is presumed that they were kera-
tinocytes. Artemin overexpression in mice, where the
artemin gene was inserted after the K14 keratin pro-
moter, produced a similar pattern of phenotypic changes
of TRP channel expression in primary afferents, as well
as behavioral changes, as found in the present study
[2,23]. The in situ hybridization signals showing artemin
mRNA apparently increased in the epidermis 1d after
CFA injection (Figure 1O, R) suggesting that keratino-
cytes express increased artemin mRNA. A paper exam-
ining human atopic dermatitis patients’ skin showed that
fibroblasts, which accumulated in the lesion, expressed
increased artemin [32]. Therefore, the precise cellular
origin of increased artemin in the inflamed epidermis/
dermis is not clear at this point. In the dermis or hypo-
dermis, there were a number of cells showing intensified
signals of artemin mRNA after CFA injection. Eosin-
labeled immune cells in the dermis also expressed
increased artemin mRNA (Figure 1S); however, the
detailed classification of the cells was not determined
due to methodological limitations. In addition, smooth
muscle-like cells in the blood vessels in the dermis
expressed increased NGF mRNA after CFA injection
(Figure 1K). An interesting point on NGF/artemin
Figure 7 Artemin increases Ca2+ activity through TRPA1 and TRPV1 in primary cultured DRG neurons. A-F, I-N: Examples of a Fura-2-based
Ca2+ imaging method with DRG primary cultured neurons in vehicle- (A-C, I-K) or artemin-treated groups (D-F, L-N). The images are before stimuli
(A, D, I, L), after KCL (B, E, J, M), and after capsaicin (C, F) or AITC (K, N). G and O: The percentage of TRPV1-(G) or TRPA1- (O) expressing neurons was
significantly larger in artemin-treated neurons than amongst vehicle-treated ones. TRPV1 positive neurons were examined by application of capsaicin,
and TRPA1-expressing neurons were confirmed by the application of AITC (100 μM) and capsaicin (1 μM). H and P: The increase in the Fura ratio
(the ratio of 340/380 nm values) between the two treated groups was compared. The artemin-treated DRG neurons showed higher Fura ratios after
application of capsaicin than the vehicle-treated ones (***p < 0.001, H). However, the changes in Fura ratios in AITC/capsaicin responsive neurons
did not show a significant difference between the artemin and vehicle-treated groups (P). (mean ± SEM, *p < 0.05, ***p < 0.001, compared with the
vehicle group).
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tion is that it was much longer than that of NGF; the
NGF increase terminated 1d after CFA injection. In
contrast, the artemin increase started at 1d and con-
tinued for a few days. The long-term effects of artemin
on pain may be more important than those of NGF, at
least in the skin.
In the present study we found that artemin mRNA in-
creased in the sciatic nerve distal to the nerve injury site.
The sciatic nerve tissue was examined by RT-PCR, and
in situ hybridization did not include the injury site, indi-
cating the changes observed in the present study may
not be a direct result of changes at the nerve injury site
but may involve changes in the distal nerve, such as via
Wallerian degeneration. Compared to NGF, artemin
mRNA showed large and long-lasting upregulation after
nerve injury. The increase was first detectable 7d after
injury and continued for at least 3 weeks. These data
also indicate that artemin has the characteristics of a
long-lasting trophic factor in primary afferents.In terms of regulatory effects of artemin on gene ex-
pression in primary afferents, most studies suggested a
positive role of artemin on TRP channel expression
[23,24,32]. For example, TRPA1/V1 increases with arte-
min overexpression in mice and artemin and TRPA1/V1
increases in situ in inflamed tissue. In the present study,
we confirmed the direct regulatory effect of artemin on
TRPA1/V1 expression in the primary afferent in two
ways. Firstly, mRNA analysis of DRG tissue was done by
RT-PCR and in situ hybridization after artemin injection
into the rat hindpaw in vivo (Figure 3). Secondly,
TRPA1/V1 mRNAs were measured using cultured rat
DRG neurons (Figure 6). We could clearly show that
artemin administration significantly up-regulated the ex-
pression of TRPA1/V1 in small to medium-sized DRG
neurons, and we believe that these data are the first
demonstration of direct effects of artemin on TRP chan-
nel expression in DRG neurons.
The time-course of the up-regulation of artemin and
NGF after peripheral inflammation by CFA is intriguing
Figure 8 p38 phosphorylation regulated TRPV1/A1 expression in DRG neurons. A-C: Immunostaining of p-p38 positive DRG neurons in
naïve and PBS- and artemin-injected rats. The repetitive plantar injection of artemin increased the number of p-p38 positive neurons compared
to in the PBS control group. D: The percentages of p-p38-labeled neurons showed that repeated artemin injection increased p-p38-labeled
neurons in the DRG compared to PBS control (mean ± SEM, *p < 0.05). E and F: Colocalization of TRPV1 or TRPA1 mRNA (clusters of black grains)
and p-p38 (brown cells) using the double-labeling method with ISHH and immunohistochemistry. Arrows indicate examples of double-labeled
neurons. G, H: The percentages of TRPV1- (G) or TRPA1 (H)-expressing neurons from amongst p-p38-labeled neurons. Colocalization of TRPV1 or
TRPA1 in p-p38-labeled neurons was significantly increased after artemin injection (mean ± SEM, *p < 0.05). Bars, 20 μm (A-C, E, F). I-K: RT-PCR of
DRG primary cultured neurons with artemin (100 ng/ml) and two different doses of SB203580, 2 μM and 20 μM. The inhibition of mRNA was seen
only with 20 μM of SB203580 for TRPV1 and not observed for TRPA1 (mean ± SEM, *p < 0.05; versus artemin + vehicle group).
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crease in mRNA, in contrast to artemin which had a
more robust and long-lasting upregulation in the skin
after CFA injection. This is consistent with data from
mouse skin after CFA injection [24]. Also the double-
labeling experiments in the present study (Figure 4)
indicate a higher colocalization between TRPA1/V1and the artemin receptor, GFRα3, compared to that
between TRPA1/V1 and the NGF receptor, TrkA.
These data also support the pivotal role of periphery-
derived artemin as a regulator of TRP channels in pri-
mary afferents. Considering that the injection of the
rat plantar surface with artemin induces a significant
increase of TRPV1/A1 expression in small to medium-
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min on TRP channel expression and nociception is
likely to be distinct and potent, like with NGF.
The p38 MAPK pathway has an important modulatory
role of TRPV1 [26,27,33] and TRPA1 [34-36]. Ji et al.,
[26] found that activation of p38 in the DRG by
periphery-derived NGF increases TRPV1 levels in noci-
ceptor peripheral terminals and contributes to the main-
tenance of inflammatory pain. Therefore, we examined
whether artemin regulates TRP channels in the DRG
through the p38 MAPK pathway, and found the up-
regulation of p-p38 and colocalization of p-p38 and
TRPA1/V1 in the DRG in vivo after artemin treatment.
However, we demonstrated that the p38 inhibitor
SB203580 significantly suppressed artemin-induced up-
regulation of TRPV1 in a DRG culture, and did not
affect on TRPA1 expression. As previous papers sug-
gested that p38 activation in small to medium-sized
DRG neurons might have a very important role in the
expression of TRPV1 or other pain related molecules
[26,27,33], the present finding that artemin-induced p38
has a pivotal role in TRPV1 channel expression is not
surprising. Our data suggest that TRPA1 upregulation
by peripherally increased artemin is mediated through
different signaling cascades from p38 MAPK pathway,
and the precise mechanism how artemin regulates
TRPA1 expression in primary afferent neurons should
be clarified. NGF has been long recognized as the only
regulator of pain-related molecules in nociceptive neu-
rons of primary afferents. However, we found increased
artemin synthesis in the peripheral tissue after inflam-
mation or nerve injury, which may have an important
role in the regulation of TRP channel expression, as is
the case with NGF.
Conclusion
We have demonstrated that artemin increases locally in
skin over long periods of time after peripheral inflamma-
tion and in the sciatic nerve following Wallerian degen-
eration after nerve injury. Repeated artemin injections
into the periphery changed the gene expression of
TRPA1/V1 and TRPA1 in DRG neurons and induced
mechanical and heat hyperalgesia. Our data using pri-
mary cultured DRG neurons suggest that TRPV1 upreg-
ulation by artemin is mediated through p38 MAPK,
however artemin-induced TRPA1 increase may have a
different signaling pathway. All findings here indicate
the important role of peripherally-derived artemin on
the regulation of TRPV1/A1 in DRG neurons.
Methods
Animals
All animal experiments conformed to the regulations of
the Hyogo College of Medicine Committee on AnimalResearch and were performed in accordance with the
guidelines of the National Institutes of Health on animal
care. Male Sprague Dawley rats, aged 4 weeks for the
DRG primary culture neurons and calcium imaging
study, and those weighing 200–250 g for the other stud-
ies, were used. Plantar injection was performed under
ether anesthesia, and surgical procedures were per-
formed under sodium pentobarbital (50 mg/kg, i.p.)
anesthesia. Additional doses of the anesthetics were
given as needed. 50% Complete Freund’s adjuvant saline
(CFA, 100 μl) was injected into the plantar surface of
the left hind paw. Recombinant mouse artemin (R & D
systems, 20 μg/ml, 100 μl) was injected into the plantar
surface. DMSO was used as a vehicle control for the
models using p38 inhibitor with the DRG primary cul-
ture neurons. L5 spinal nerve ligation was performed
with some modifications to the original SPNL model
[37]. After anesthetizing the rats, the hair of the lower
back was shaved and the skin was sterilized with 0.5%
chlorhexidine. Using sterilized operating instruments,
the left L5 spinal nerve was isolated and tightly ligated
with 3–0 silk thread (L5 SPNL). Thereafter, the ligated
spinal nerve was cut on the distal side to the ligated part.
The right side was not subjected to any surgery. The
wound was washed with distilled saline and sutured with
3–0 silk thread.
In situ hybridization histochemistry
Rats were perfused transcardially with 1% paraformalde-
hyde in 0.1 M phosphate buffer (PB, pH 7.4) followed by
4% paraformaldehyde in 0.1 M PB. The bilateral L4-5
DRG neurons and sciatic nerve (1 cm length) 2 cm distal
to the ligation were removed, and postfixed in the same
fixative at 4°C overnight, followed by immersion in 20%
sucrose in 0.1 m phosphate buffer at 4°C for 2 d. There-
after, they were rapidly frozen in powdered dry ice, and
cut on a cryostat at a thickness of 8 μm. For plantar skin
samples, rats were sacrificed by decapitation under deep
ether anesthesia. The plantar skin surface was removed,
rapidly frozen, and cut on a cryostat at a thickness of
5 μm. Sections were thaw-mounted onto MAS-coated
glass slides (Matsunami, Osaka, Japan). The details of
the dual ISHH procedure have been described in our
previous study [6]. For autoradiography, the sections
were coated with NTB emulsion (Eastman Kodak, Roch-
ester, NY) diluted 3:2 with distilled water at 45°C and ex-
posed for 1–2 weeks in light-tight boxes at 4°C. After
development in D-19 (Eastman Kodak) and fixation in
24% sodium thiosulfate, the sections were stained with
hematoxylin-eosin, dehydrated in a graded ethanol
series, cleared in xylene, and coverslipped [6].
For the co-expression study of the two different mRNAs
on DRG neurons in naive rats, we used 35S-labeled
RNA probes for TRPV1 (GenBank accession number
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accession number AY496961, nucleotides 302–788),
and DIG-labeled probes for TrkA (GenBank accession
number X05137, nucleotides 560–979) and GFRα3
(GenBank accession number AF184920, nucleotides
164–604) in the same sections.
Immunohistochemistry
The protocol for immunohistochemistry was based on
the published ABC (Vectastain Elite ABC kit, Vector,
CA, USA) method [38]. The DRG sections on the MAS-
coated glass were preincubated in TBS containing 10%
normal goat serum (NGS) for 1 hour, then incubated in
primary antibody for p-p38 (1:500, Cell Signaling Tech-
nology) in the same solution for 48 hours at 4°C. The
sections were washed in TBS and then incubated in bio-
tinylated anti-rabbit IgG (1:200; Vector Laboratories,
Burlingame, CA) in TBS containing 5% NGS for 2 hours
at 4°C, followed by incubation in avidin-biotin–peroxid-
ase complex (Vectastain Elite ABC kit, Vector, CA,
USA) for 1 hour at room temperature. The horseradish
peroxidase reaction was developed in 0.1 M Tris-buffered
saline, pH 7.4, containing 0.05% 3,39-diaminobenzidine
tetrahydrochloride (Sigma, Steinheim, Germany), and
0.01% hydrogen peroxidase. Sections were then washed in
TBS, mounted on slides, dried, and cover-slipped.
Image analysis
The statistical analyses of ISHH have been previously
described in detail [38-40]. At least 3,000 neuronal pro-
files from four rats were quantified for each antisense
probe in the single ISHH study. Measurements of the
density of silver grains over randomly selected tissue
profiles were performed using a computerized image
analysis system (NIH Image, version 1.61), in which only
neuronal profiles that contained nuclei were used for
quantification. At a magnification of 200x and with
brightfield illumination, upper and lower thresholds of
gray level density were set such that only silver grains
were accurately discriminated from the background in
the outlined cell or tissue profile and were read by the
computer, pixel by pixel. Subsequently, the area of dis-
criminated pixels was measured and divided by the area
of the outlined neuronal profile, giving a grain density
(%) for each cell. To reduce the risk of biased sampling
of the data because of varying emulsion thickness, we
used a signal-to-noise (S/N) ratio for each cell in each
tissue. The S/N ratio of an individual neuron and its
cross-sectioned area, which was computed from the out-
lined profile, was plotted. Based on this scattergram,
neurons with a grain density 5-fold that of the back-
ground level or higher (5 S/N ratio) were considered
positively labeled for TRPA1, TRPV1 and GFRα3
mRNAs. To distinguish cell size-specific changes, wecharacterized the DRG neurons as small (<600 μm2),
medium (600-1200 μm2) and large (>1200 μm2), according
to their cross-sectional area. Since a stereological ap-
proach was not used in this study, quantification of the
data may represent a biased estimate of the actual num-
bers of neurons. The number of positively labeled DRG
neurons was divided by the number of neuronal profiles
counted in each DRG. Data are expressed throughout as
mean ± SEM (%). The level of statistically significant
difference was taken to be a probability of less than
5% (p < 0.05) [40].
Reverse transcription-polymerase chain reaction (RT-PCR)
For the CFA plantar injection model, the rats were sacri-
ficed by decapitation under deep ether anesthesia at 3 h,
9 h, 12 h, 1d, 3d and 7d after CFA injection (n = 4 at
each time point). The plantar skin was removed bilat-
erally. The SNL model rats were sacrificed by decapita-
tion under deep ether anesthesia at 1d, 3d, 5d, 7d, 14d
and 21d after the operation (n = 4 at each time point).
The bilateral 1 cm long sciatic nerves were removed
2 cm away from the ligation. The samples were removed
and rapidly frozen with powdered dry ice. They were
stored at −80°C until use. Skin samples were cut on a
cryostat at 40 μm thickness and collected in a 2.0 ml
collection tube. Extraction of total RNA was carried out
using the RNA extraction reagent ISOGEN (Nippon
Gene, Tokyo, Japan). For the DRG primary culture neu-
rons, the incubated culture was washed with TBS and
collected with 1 ml of ISOGEN. All samples were ho-
mogenized in 1 ml of ISOGEN regent, mixed with
200 μl of chloroform, and centrifuged for 15 minutes at
4°C and 12,000 g. The supernatant was mixed with
500 μl of isopropyl alcohol and centrifuged again under
the same conditions.
For purification of total RNA from these samples, a
PureLink® RNA Micro Kit (Invitrogen, CA, USA) was
used. RNA extraction was quantified by measurement of
optical density at 260 nm. Samples of 3 μg of total RNA
were mixed with 25 μl RT mixture to a final concentration
200 units of M-MLV reverse transcriptase (Promega,
Madison, WI), 20 units of RNase inhibitor (Promega),
0.8 μM dNTP, and 1 μg oligo dT primer in 1 x reaction
buffer (pH 7.5; Promega). RT was carried out at 37°C for
60 minutes, following inactivation at 70°C for 10 minutes.
The forward and reverse primers specific for rat NGF,
artemin, TRPV1, TRPA1, GFRα3 and GAPDH were de-
signed as shown in Table 1. The PCR reaction was per-
formed in 10 μl of Taq PCR master mix kit (QIAGEN,
CA, USA) and cDNA with a pair of 10-pmol primers for
each gene on a DNA Thermal Cycler (GeneAmp PCR
System 9700, Applied Biosystems, Foster City, CA).
The PCR conditions for temperature cycles were dif-
ferent for each gene. The resulting PCR products were






NGF M36589 652-671 1016-997
Artemin NM053397 852-871 1252-1233
TRPV1 AF029310 149-168 505-486
TRPA1 AY496961 302-321 788-769
GFRα3 AF184920 164-183 604-585
GAPDH M17701 80-99 350-331
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ing ethidium bromide and visualized with UV illumin-
ation. Each pair of forward and reverse primers
presented a single band with the expected size.
Behavioral studies
Adult male Sprague–Dawley rats (200-250 g) were used
for the behavioral analyses. Room temperature and
lightning were kept stable for all testing. Rats were suffi-
ciently habituated in the environment and tested for
basal pain hypersensitivity. Thereafter, rats were admin-
istered 100 μl of artemin or PBS into the left hindpaw.
One day after the administration, mechanical and ther-
mal behavioral tests were started with a Dynamic Plantar
Aesthesiometer (Ugo Basile, Italy) and the Hargreaves
radiant heat apparatus, respectively. The Dynamic Plan-
tar Aesthesiometer was used as the automated von Frey
hair system. The threshold was taken as the force ap-
plied to the plantar surface at which the rats withdrew
from it. For the 5-consecutive-day injection model, test-
ing was performed just before injection. The first value
for each test was removed from the data, and the aver-
ages from the subsequent three values were taken as the
thermal and mechanical thresholds.
DRG primary culture neurons
DRG neurons were removed from 4-week Sprague–
Dawley rats with a sterile technique, and were put into
ice-cold Earle’s balanced salt solution (EBSS, Sigma). In
order to remove the adhered fat and connective tissue,
the DRG neurons were placed in 2 ml of EBSS with
1.25 mg/ml of collagenase P (Sigma) for 2 hours at 37°C.
After incubation, the cell suspension was centrifuged for
5 minutes at 1000 rpm and the cell pellet was re-
suspended in EBSS. The DRG neurons were mechanic-
ally dissociated with a Pasteur pipette in Neurobasal
medium, 10% FCS, D-MEM, 2% B27 supplement plus
(Miltenyi Biotec Inc, CA, USA), SMPCG and L-Glu.
After dissociation, the cell suspension was filtered,
plated onto poly-L-lysine coated plates, and incubated
with the medium for 2 days. In order to exclude the ef-
fect of other growth factors, Neurobasal with 2% of B27supplement plus, SMPCG and L-glu were used. For the
artemin group, recombinant mouse artemin (100 ng/ml)
was added to the medium. In the experiment with p38
MAPK inhibitor, SB203580 [4-(4-fluorophenyl)-2-(4-
methylsulfinylphenyl)-5-(4-pyridyl)-1H-imidazole] (Calbio-
chem, La Jolla, CA, USA) dissolved with DMSO was
administered to the medium with artemin at the same
time. SB203580 were used with two different dose:
2 μM and 20 μM. After an 18-hour incubation period,
the DRG neurons were removed with a cell scraper
and put into 1 ml of ISOGEN (Nippon Gene, Tokyo,
Japan).Ca2+ imaging study
Ratiometric calcium imaging was performed using an
Olympus fluorescence microscope equipped with a vari-
able filter wheel (Sutter Instruments, Novato, CA, USA)
and a cooled digital CCD camera (Hamamatsu, Shizu-
oka, Japan). Dual images (340 and 380 nm excitation,
510 nm emission) were collected and pseudo-color
ratiometric images were monitored every 2 seconds dur-
ing the experiment using an Axon Imaging Workbench
5.0 (INDEC BioSystems, Inc, Mountain View, CA, USA)
[41]. The DRG neurons were removed from 4-week
Sprague–Dawley rats. After dissociation of the DRG
neurons, the cell suspension was placed onto coverslips
coated with poly-L-lysine and cultured for 18 to 24 hours
with the same method as above (see DRG primary cul-
ture neurons in the Methods section). They were
loaded with 4μM Fura-2 acetoxymethyl ester (Nacalai
Tesque, Kyoto, Japan) for 40 minutes at 37°C. After
the incubation, the coverslips were placed in a cham-
ber connected to a gravity flow system to deliver
various chemicals. One microscopic field on the cover-
slip, which contained 20 to 30 neurons, was randomly
selected and measured. The data were collected from
a total of 20 fields in each group (n = 4 each group).
The system was loaded with a standard bath solution
containing 140 mM NaCl, 5 mM KCl, 2 mM MgCl2,
2 mM CaCl2, 10 mM HEPES and 10 mM glucose
pH7.4 (adjusted with NaOH). A standard bath solu-
tion was first applied to the cells for 20 seconds,
followed by KCl (50 mM) for 20 seconds, and the cells
were then washed with the standard bath solution for
5 minutes. For the TRPV1 study, capsaicin (200nM)
was applied for 20 seconds and it was washed out
again with the standard bath solution for 3 minutes.
For the TRPA1 study, AITC (100 μM) was applied for
20 seconds and it was washed out for 3 minutes.
Thereafter, capsaicin (1 μM) was perfused for 20 sec-
onds. The number of agonist-responding neurons rela-
tive to KCl-responding neurons in each selected
microscopic field was calculated and summed.
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All results are expressed as mean ± SEM. An unpaired
t-test was used for RT-PCR of DRG primary culture
neurons and the calcium imaging data to compare the
groups. A one-way ANOVA was used for the RT-PCR of
CFA plantar injected skin and DRG primary culture with
the p-p38 inhibitor. For all behavioral testing, a two-way
ANOVA followed by Bonferroni posttests was used. Dif-
ferences were accepted as significant if the probability
was less than 5% (p < 0.05). All emulsion-coated slides
were digitized with a Nikon DIAPHOT-300 microscope
connected to a Nikon DXM1200 digital camera. We
used Adobe Photoshop Element 10.0 (Adobe Systems,
Mountain View, CA, USA) to optimize the images and
prepare all figures.
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